Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000102 · ClinicalTrials.gov registry record · Phase 1
Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
A Phase 1 study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- Phase 1
- Development phase
NCT00000102 is a Phase 1 study that has completed, run by National Center for Research Resources (NCRR).
The verdict
NCT00000102, a Phase 1 study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
This study will test the ability of extended release nifedipine (Procardia XL), a blood pressure medication, to permit a decrease in the dose of glucocorticoid medication children take to treat congenital adrenal hyperplasia (CAH).
Interventions
- DRUG Nifedipine
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000102
The ClinicalTrials.gov registry entry for NCT00000102 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nifedipine is the first listed.
NCT00000102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000102 about?
NCT00000102 is a clinical study titled "Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets". This study will test the ability of extended release nifedipine (Procardia XL), a blood pressure medication, to permit a decrease in the dose of glucocorticoid medication children take to treat congenital adrenal hyperplasia (CAH).
What is the current status of trial NCT00000102?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00000102?
The interventions under investigation include: Nifedipine (DRUG).
Who is sponsoring clinical trial NCT00000102?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.